Denali Therapeutics DNLI
NASDAQ DNLI
$19.85 -0.51 (-2.50%)
At close: Nov 10, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Amortization - Intangibles (2026)

Updated

Denali Therapeutics (DNLI) reported Amortization - Intangibles of $800,000 for Q3 2026, up 6.7% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Amortization - Intangibles (2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Denali Therapeutics' Amortization - Intangibles came in at $1.55 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 800,000.00
Jun 30, 2026 750,000.00
API Access

Denali Therapeutics Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=DNLI&period=max&api_key=YOUR_API_KEY